Delivery Order SPE2DB20D9331-SPE2DB25FL1M8
Award Date 7/8/25
Potential Completion Date 7/29/25
Potential Value $148K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The order is for 3,750 units of the pharmaceutical product ASPARLAS (5 ml vials) with a potential value of $124,714.50 and a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand-name and generic prescription and over-the-counter drug supplies to the federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $138,073.90 and an ultimate completion date of May 29, 2024. DMS Pharmaceutical Group will provide 3,750 units of the pharmaceutical product ASPARLAS (5 ML vial) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The award, valued at $55,229.58, is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS (5 mL vial). This order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $27,614.78 contract is to provide 3,750 units of the pharmaceutical product ASPARLAS (5 mL vials) with an ultimate completion date of April 10, 2024. DMS Pharmaceutical Group holds a $4,999,999 indefinite delivery vehicle (IDV) contract with DLA under the SPE2DB program to supply a broad range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ml vials. The contract has a firm-fixed price of $148,084.30 and a period of performance ending on June 26, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3,750 units of the 5 milliliter vial of the pharmaceutical product ASPARLAS. The total potential value of the order is $82,844.34. The contract has a completion date of February 7, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,616.86 contract is for the delivery of 3,750 units of the drug ASPARLAS (5 mL vial) with a period of performance through April 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $82,844.34, is for the delivery of 3,750 units of the 5 ML vial pharmaceutical product ASPARLAS, with a completion date of December 30, 2024. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $138,073.90, is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ML vials. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC,...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 3,750 units of the pharmaceutical product ASPARLAS in 5 mL vials. The contract has a potential value of $55,229.58 and a completion date of March 13, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA valued at up to $4,999,999, which enables the agency to order a...